corydalmine has been researched along with Chronic Pain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, YN; Dai, WL; Jiang, N; Liu, JH; Liu, XT; Yan, B; Yu, BY | 1 |
1 other study(ies) available for corydalmine and Chronic Pain
Article | Year |
---|---|
Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner.
Topics: Analgesics, Opioid; Animals; Berberine; Cell Line, Tumor; CHO Cells; Chronic Pain; Cricetinae; Cricetulus; Dopamine Antagonists; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Male; MAP Kinase Signaling System; Mice; Morphine; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Opioid, mu | 2018 |